Use of non-selective B-blockers is safe in hospitalised decompensated cirrhosis patients and exerts a potential anti-inflammatory effect: Data from the ATTIRE trial

BACKGROUND: Nonselective B-blockers (NSBBs) are believed to have pleiotropic effects beyond reducing portal pressure. However, studies also report potential harm in patients hospitalized with cirrhosis and ascites. We therefore investigated whether NSBB use at ATTIRE trial entry (Albumin to prevent...

Descripción completa

Detalles Bibliográficos
Autores principales: Tittanegro, Thais, China, Louise, Forrest, Ewan, Kallis, Yiannis, Ryder, Stephen D., Wright, Gavin, Freemantle, Nick, O'Brien, Alastair
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9672423/
https://www.ncbi.nlm.nih.gov/pubmed/36407574
http://dx.doi.org/10.1016/j.eclinm.2022.101716

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9672423/
https://www.ncbi.nlm.nih.gov/pubmed/36407574
http://dx.doi.org/10.1016/j.eclinm.2022.101716

Ejemplares similares